News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Navigating Giant Cell Arteritis: Diagnosis, Management, and the Road Ahead

EP. 1: An Overview of Giant Cell Arteritis (GCA): Common Signs and Symptoms

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

November 24th 2025

EP. 2: The Underlying Causes of GCA: Environmental and Genetic Factors

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

November 24th 2025

EP. 3: Current Gaps in Diagnostic Criteria Standards: Key Factors That Inform Diagnostic Decisions

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 3rd 2025

EP. 4: Non-Cranial Symptoms in GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 3rd 2025

EP. 5: Imaging Modalities for Diagnosing GCA: What Clinicians are Doing in Clinic

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 10th 2025

EP. 6: Discussing the Overlap of Polymyalgia Rheumatica in Patients With GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 10th 2025

EP. 7: Diagnostic Blood Testing in GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 17th 2025

EP. 8: Expert Perspectives on the Reasons for Diagnostic Delay in GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 17th 2025

EP. 9: The Physical and Mental Quality of Life Impacts of GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 24th 2025

EP. 10: Current Standards of Care in GCA Treatment

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

December 24th 2025

EP. 11: Real-World Complications Using Steroids to Treat GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 8th 2026

EP. 12: Current Pathway Treatment Targets in GCA

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 8th 2026

EP. 13: Reflecting on the Trial Landscape in GCA and History of Approved Agents

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 15th 2026

EP. 14: Clinical Experience with Tocilizumab and Upadacitinib in GCA Treatment

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 15th 2026

EP. 15: The Trial Design and Interim Results From the GCAptAIN Trial

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 22nd 2026

EP. 16: Experts Discuss the REPLENISH Trial for Polymyalgia Rheumatica

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 22nd 2026

EP. 17: Reflecting on Trial Limitations in GCA: Painting a Future for IL-17A Targeting Therapies

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 29th 2026

EP. 18: Hope on the Horizon: The Future of GCA Treatment

ByRobert Spiera, MD,John Stone, MD, MPH,Anisha Dua, MD, MPH,Leonard Calabrese, DO

January 29th 2026

Trending on HCPLive

4 Nephrology Headlines You Missed in June 2026

FDA News Recap: Novel Drug Approvals in First Half of 2026

6 Cardiology Headlines You Missed in June 2026

Heterogeneity, Refractory Symptoms, and Multidimensional Care in Pediatric Functional Constipation and IBS-C

How Should Dermatology Clinicians Address Online Myths? With Shannon Trotter, DO